
Audio-based Detection of Anxiety and Depression via Vocal Biomarkers
September 28, 2023
This study focuses on mental healthcare, specifically on the detection of anxiety and depression. We present a comparison of results based on the application of various model/feature combinations on the task of detecting anxiety and depression from audio signals of spontaneous speech. The adopted models comprise several different advanced deep neural networks, including CNN, LSTM, and attention networks, and are compared against traditional, shallow machine learning models. Our models are trained based on self-assessment scores: GAD-7 for anxiety and PHQ-8 for depression.
Our best models obtain an unweighted average recall (UAR) of 0.60 for anxiety and 0.63 for the depression task. The result on the anxiety task falls short of the reported self-scored GAD-7 screening reliability of 0.64 just by a small margin and hence shows that this audio-based model can be deployed as an anxiety and depression screening tool. Considering that our models are trained and evaluated on the self-measured, subjective, and hence potentially “noisy” labels, the model performance is highly meaningful and promising towards the goal of automatically and objectively identifying anxiety and depression disorders based on everyday speech, without the time-consuming task of answering the lengthy self-evaluating questionnaires.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp














